Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01744340
Title A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors howard safran
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Montefiore Bronx New York 10467 United States Details
Memorial Hospital Pawtucket Rhode Island 02860 United States Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
The Miriam Hospital Providence Rhode Island 02904 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field